相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual blockade of aldosterone and angiotensin II additively suppresses TGF-β and NADPH oxidase in the hypertensive kidney
Maristela Lika Onozato et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Renin-angiotensin system and cardiovascular risk
Roland E. Schmieder et al.
LANCET (2007)
Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis
A. B. Kramer et al.
KIDNEY INTERNATIONAL (2007)
The renin-angiotensin system and diabetic nephropathy
Susan B. Gurley et al.
SEMINARS IN NEPHROLOGY (2007)
The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy
Sachiko Matsumoto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
Christine Guo et al.
ENDOCRINOLOGY (2006)
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt et al.
KIDNEY INTERNATIONAL (2006)
Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats
K. H. Han et al.
KIDNEY INTERNATIONAL (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection
Atsuhisa Sato et al.
HYPERTENSION RESEARCH (2006)
Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy
Kohzo Takebayashi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Beneficial impact of spironolactone in diabetic nephropathy
KJ Schjoedt et al.
KIDNEY INTERNATIONAL (2005)
Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study
S Bianchi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1
LJ Ma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis
G Wolf
ANTIOXIDANTS & REDOX SIGNALING (2005)
Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats
G Fujisawa et al.
KIDNEY INTERNATIONAL (2004)
Spironolactone and angiotensin receptor blockerin nondiabetic renal diseases
K Nitta et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
KJ Schjoedt et al.
DIABETOLOGIA (2004)
Effect of aldosterone on renal transforming growth factor-β
I Juknevicius et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model
XY Zhou et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
被撤回的出版物: The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study (Retracted article see vol 23, pg 818, 2006)
R Rachmani et al.
DIABETIC MEDICINE (2004)
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
ER Blasi et al.
KIDNEY INTERNATIONAL (2003)
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
A Sato et al.
HYPERTENSION (2003)
Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats
G Miric et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
NJ Brown et al.
KIDNEY INTERNATIONAL (2000)
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?
GL Bakris et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
